| Name: | Alogliptin Impurity 29 |
| Catalogue No. | VL5900025 |
| CAS No. | 1246610-74-1 |
| Molecular Formula | C23H29N5O4 |
| Molecular Weight | 439.51 g/mol |
| Status | In-Stock |
| IUPAC Name | (R)-tert-Butyl (1-(3-(2-cyanobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)piperidin-3-yl)carbamate |
| Description | Alogliptin Impurity 29 (CAS No: 1246610-74-1) or (R)-tert-Butyl (1-(3-(2-cyanobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)piperidin-3-yl)carbamate,a formulation and process related adultrant of Alogliptin, a noncovalent inhibitor of the serine protease dipeptidyl peptidase IV (DPP-4). |
| References | Scott, Lesley J. “Alogliptin.” Drugs, vol. 70, no. 15, Oct. 2010, pp. 2051–72, https://doi.org/10.2165/11205080-000000000-00000. Moritoh, Yusuke, et al. “The Dipeptidyl Peptidase-4 Inhibitor Alogliptin in Combination with Pioglitazone Improves Glycemic Control, Lipid Profiles, and Increases Pancreatic Insulin Content in Ob/Ob Mice.” European Journal of Pharmacology, vol. 602, no. 2-3, Jan. 2009, pp. 448–54, https://doi.org/10.1016/j.ejphar.2008.11.017. |
